Going circular: history, present, and future of circRNAs in cancer.

Pisignano, Giuseppina; Michael, David C; Visal, Tanvi H; Pirlog, Radu; Ladomery, Michael; Calin, George A

Pisignano, Giuseppina; Michael, David C; Visal, Tanvi H; Pirlog, Radu; Ladomery, Michael; Calin, George A.

Afiliação

Pisignano G; Department of Life Sciences, University of Bath, Claverton Down, Bath, BA2 7AY, UK. gp529@bath.ac.uk.
Michael DC; Department of Life Sciences, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
Visal TH; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pirlog R; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ladomery M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Calin GA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Oncogene ; 42(38): 2783-2800, 2023 09.

Article em En | MEDLINE | ID: mdl-37587333

Assuntos

Neoplasias; RNA Circular; Humanos; RNA Circular/genética; Neoplasias/genética; Carcinogênese; RNA/genética; Transformação Celular Neoplásica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Circular / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google